These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33820400)

  • 1. Minimal invasive surfactant therapy in preterm infants with respiratory distress syndrome: a single-center experience.
    Rallis D; Drogouti E; Karagianni P; Soubasi-Griva V; Tsakalidis C
    Minerva Pediatr (Torino); 2024 Feb; 76(1):72-78. PubMed ID: 33820400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
    Gupta BK; Saha AK; Mukherjee S; Saha B
    Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies.
    Aguar M; Cernada M; Brugada M; Gimeno A; Gutierrez A; Vento M
    Acta Paediatr; 2014 Jun; 103(6):e229-33. PubMed ID: 24628379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
    Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
    Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
    Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive surfactant therapy
    Elbaz Y; Portnov I; Lurie-Marcu B; Shinwell ES
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6802-6806. PubMed ID: 34024234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
    Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
    Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Beractant Administration by Thin Catheter vs Intubation-Surfactant-Extubation (INSURE) in Preterm Infants Less than 34 Weeks Gestational Age with Respiratory Distress Syndrome - A Single Centre Experience.
    Patra S; Manerkar S; Kaur S; Kalathingal T; Kalamdani P; Bhisikar S; Mondkar J
    J Neonatal Perinatal Med; 2023; 16(2):239-245. PubMed ID: 37270819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
    Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
    Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.